Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide plus CHOP in newly diagnosed peripheral T-cell lymphoma
ChiCTR-OIC-17011303Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tucidinostat in peripheral T-cell lymphoma (PTCL), sponsored by First Affiliated Hospital of Soochow University. Started May 2017; status: recruiting.
02
Drugs
tucidinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on ChiCTR-OIC-17011303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-17011303.